Cecal volvulus associated with carfilzomib use for al amyloidosis.

Shahaf Tuler Jaspreet Kaur Constantin A Dasanu

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)

The causality between volvulus and the treatment with carfilzomib was probable, with a documented score of 6 on the Naranjo probability nomogram. The exact mechanism behind this effect of carfilzomib has yet to be elucidated.

Keyphrases

multiple myeloma
emergency department
lymph node metastasis
squamous cell carcinoma
adverse drug